Ionis Pharmaceuticals
(IONS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -124,323 | -269,722 | -217,292 | -170,300 | -65,165 |
| Depreciation Amortization | 2,050 | 34,867 | 28,183 | 20,536 | 10,413 |
| Accounts receivable | 11,624 | 36,358 | 55,251 | 55,145 | 35,774 |
| Accounts payable and accrued liabilities | -10,295 | 1,094 | 5,607 | -2,672 | 2,878 |
| Other Working Capital | -55,004 | 7,571 | 38,448 | 47,748 | -3,761 |
| Other Operating Activity | 41,956 | -84,538 | 15,628 | -203 | -11,789 |
| Operating Cash Flow | $-133,992 | $-274,370 | $-74,175 | $-49,746 | $-31,650 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -313,915 | -496,620 | -459,690 | -282,820 | -284,018 |
| PPE Investments | -10,472 | 238,362 | -11,582 | -6,040 | -2,705 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -826 |
| Purchase Sale Intangibles | -1,253 | -4,378 | -3,511 | -1,993 | N/A |
| Other Investing Activity | -1,253 | -4,378 | -3,511 | -1,993 | 0 |
| Investing Cash Flow | $-325,640 | $-262,636 | $-474,783 | $-290,853 | $-287,549 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -39 | -50,686 | -89 | N/A | N/A |
| Common Stock Issued | 2,560 | 6,373 | 6,030 | 3,462 | 1,848 |
| Other Financing Activity | 489,566 | -10,982 | -10,217 | -9,572 | -9,173 |
| Financing Cash Flow | $492,087 | $-55,295 | $-4,276 | $-6,110 | $-7,325 |
| Exchange Rate Effect | 104 | -418 | -964 | -565 | -154 |
| Beginning Cash Position | 276,472 | 869,191 | 869,191 | 869,191 | 869,191 |
| End Cash Position | 309,031 | 276,472 | 314,993 | 521,917 | 542,513 |
| Net Cash Flow | $32,559 | $-592,719 | $-554,198 | $-347,274 | $-326,678 |
| Free Cash Flow | |||||
| Operating Cash Flow | -133,992 | -274,370 | -74,175 | -49,746 | -31,650 |
| Capital Expenditure | -10,472 | -15,721 | -11,582 | -6,040 | -2,705 |
| Free Cash Flow | -144,464 | -290,091 | -85,757 | -55,786 | -34,355 |